[14] reported that disruption of chemosensory signaling by the loss of TRMP5 abrogated tuft cell expansion and IL-25 upregulation on mice infected with T. NBI-98782 (2 wppt) and 2?weeks after secondary infection NBI-98782 with (2 wpsi). Vertical bars represent the standard deviation. a: significant differences with respect to na?ve mice controls; b: significant differences between groups (has been extensively used as an experimental model to study the factors determining NBI-98782 resistance to intestinal infections. In the study reported here, we assessed the role of IL-25 in the generation of resistance in mice infected with were determined, as were the consequences of IL-25 production in terms of polarization of the immune response and resistance to infection. Results Our results show that the role of IL-25 in the polarization of the immune response differs between the primary and secondary immune responses. IL-25 is required for the development of a Th2 phenotype in primary infections, but it can also promote the differentiation to Th2 memory cell subsets that enhance type-2 immunity in memory responses. However, the development of Th2 responses does not induce resistance to infection. The Th2 phenotype does not elicit resistance, and IL-25 is responsible for the resistance regardless of its type-2 cytokine activity and activation of signal transducer and activator of transcription (STAT6). Alternative activation of macrophages induced by IL-25 can be implicated in the resistance to infection. Conclusions In contrast to primary infection, secondary infection elicits a type-2 immune response even in the absence of IL-25 expression. Despite the development of a type-2 NBI-98782 response, mice are susceptible to secondary infection associated with the lack of IL-25. Resistance to infection Rabbit Polyclonal to CD40 is due to the production of IL-25, which acts autonomously from Th2 response in terms of parasite clearance. Keywords: Interleuquin-25, Intestinal helminth, Th2, Resistance, Trematoda, Echinostoma caproni Background Intestinal helminth infections are common in humans and animals, especially in developing regions of Africa, Asia and the Americas [1C3]. In humans, these parasitic infections generate substantial morbidity and produce relevant physical and mental disorders that are often aggravated in the presence of serious economic problems [2]. In addition, infections by intestinal helminths compromise the health and productivity of livestock worldwide [3]. At the present time, the impact of intestinal NBI-98782 helminth infections is primarily managed and reduced by treatment with anthelminthic drugs. However, the progressive emergence of resistance to these drugs limits their utility and, in addition, infections do not generate protective immunity, resulting in continuous reinfections in environments of poverty and poor sanitary conditions. To date, no effective vaccines have been developed to protect humans or animals from helminth infections. A major obstacle to successful immunization, among other factors, is the lack of knowledge on how protective immunity is selected after infection [4]. Resistance to intestinal helminths is based on the generation of T helper 2 (Th2)-cell responses in a complex process that involves the interaction between innate and adaptative mechanisms [5C7]. Protective Th2 immunity against intestinal helminths is initiated and amplified by the epithelial-derived alarmin cytokines, including interleukin (IL)-25, IL-33 and thymic stromal lymphopoietin (TSLP), although the immune mechanisms behind the development of these responses are poorly understood [6, 8]. In recent years, IL-25, a member of the IL-17 family of cytokines, also called IL-17E, has been considered to be a key cytokine since it promotes Th2 immunity and exerts anti-inflammatory functions via the downregulation of Th17 and Th1 responses [9C12]. IL-25 expression is generally associated with resistance to gastrointestinal helminth infections through the activation of Th2 responses that mediate effector mechanisms for parasite expulsion (which include goblet cell hyperplasia, smooth muscle hypercontractility, expression of resistin-like molecule-beta [RELM-] and intestinal mastocytosis, among others) [6]. While recent studies have uncovered the origin and the mechanisms of action of IL-25 [13C15], several doubts remain concerning the role of IL-25 in the generation of protective Th2 responses to intestinal helminth infections.